TLRY — Tilray Brands, Inc. stock price, charts and financials

QT38Tilray Brands, Inc.

Tilray Brands, Inc. (NASDAQ: TLRY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.46
-0.11-2.41%
TLRYQT38Tilray Brands, Inc.·NASDAQ
4.46-2.41%
TA
Loading chart...
Signal & projected range
Insider buying clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E-EPS (ttm)-32.34Insider Own22.15%Shs Outstand111.83MPerf Week0.66%
Market Cap622.45MForward P/E-EPS next Y-0.21Insider Trans-0.07%Shs Float134.29MPerf Month4.10%
Enterprise Value715.41MPEG-EPS next Q-0.19Inst Own-Short Float12.08%Perf Quarter-19.26%
Income-3.06BP/S0.48EPS this Y98.46%Inst Trans-Short Ratio3.27Perf Half Y-35.18%
Sales1.14BP/B0.34EPS next Y57.65%ROA-6.40%Short Interest16.23MPerf YTD-49.39%
Book/sh13.29P/C2.37EPS next 5Y-ROE-7.95%52W High22.64 -80.30%Perf Year-25.93%
Cash/sh1.93P/FCF-EPS past 3/5Y-ROIC-2.98%52W Low3.58 24.52%Perf 3Y-80.72%
Dividend Est.-EV/EBITDA44.24Sales past 3/5Y2.69% 12.27%Gross Margin27.57%Volatility5.10% 4.97%Perf 5Y-96.87%
Dividend TTM-EV/Sales0.63EPS Y/Y TTM4.32%Oper. Margin-5.18%ATR (14)0.24Perf 10Y-
Dividend Ex-Date-Quick Ratio1.37Sales Y/Y TTM1.24%Profit Margin-12.90%RSI (14)55.35Recom2.85
Dividend Gr. 3/5Y-Current Ratio2.21EPS Q/Q-330.00%SMA206.43%Beta1.91Target Price65.01
Payout0.00%Debt/Eq0.25Sales Q/Q-8.44%SMA50-0.98%Rel Volume0.86Prev Close4.57
Employees2,842LT Debt/Eq0.22EarningsOct 08SMA200-38.85%Avg Volume3.97MPrice4.46
IPO DateJul 19, 2018Option/ShortYes / YesEPS/Sales Surpr.-3471.43% 14.38%Net Debt/EBITDA10.63Volume3,414,053Change-2.41%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-02-26UpgradeRoth CapitalNeutralBuy
Jan-20-26ReiteratedRoth CapitalNeutral$4.00$10
Jan-09-26ReiteratedIndustrial Alliance Securities$10
Dec-19-25ReiteratedBernstein$1.00$10
Aug-25-25ReiteratedJefferiesBuy$1.50$2.00
Jul-29-25ReiteratedJefferiesBuy$2.50$1.50
Oct-11-24ReiteratedPiper SandlerNeutral$2.00
Sep-11-24ReiteratedJefferiesBuy$2.50
Jan-10-23ReiteratedIndustrial Alliance Securities$3.00
Sep-30-22ReiteratedBarclaysUnderweight$4.50$2.00
Latest News
Aug-05-26
Aug-04-26
Aug-03-26
Jul-30-26
Jul-29-26
Jul-29-2602:25PM
Jul-28-26
Jul-23-26
Jul-21-26
Jul-21-2610:00AM
Company

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2026
5/31/2026
FY 2025
5/31/2025
FY 2024
5/31/2024
FY 2023
5/31/2023
FY 2022
5/31/2022
FY 2021
5/31/2021
FY 2020
5/31/2020
FY 2019
5/31/2019
Total Revenue1,1419151,127
Cost of Goods Sold Incl. D&A806655797
Gross Profit335260330
Selling, General and Administrative Excl. Other361295356
Research and Development
000
Other Operating Expense3,161283,106
Operating Income-3,187-63-3,132
Interest Expense413057
Unusual Expense
Non-Operating Income (Expense)10530
Net Income Before Taxes-3,218-88-3,159
Income Taxes-16617-166
Consolidated Net Income-3,059-123-3,001
Net Income From Continuing Operations-3,052-105-2,993
Net Income-3,059-123-3,001
EPS (Recurring)-32.34-1.09-33.80
EPS (Basic, Before Extraordinaries)-32.34-1.09-33.80
EPS (Diluted)-32.34-1.09-33.80
EBITDA-2,975-39-2,919
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio0.380.670.34
Gross Margin29.3628.4229.28
Operating Margin-279.32-6.89-277.91
Net Margin-268.10-13.44-266.28
Shares Outstanding9811289
Market Capitalization437617379
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$23.61$17.95$12.30$6.65$0.99 Close Price0.00K58.22K116.44K174.66K232.88KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Gendel MitchellGlobal General CounselAug 06 '26Buy4.432,50011,075124,883Aug 07
Merton Carl AChief Financial OfficerAug 04 '26Buy4.6210,00046,200139,753Aug 04
FALTISCHEK DENISE MChief Strategy OfficerAug 03 '26Buy4.782,50011,950141,285Aug 04
FALTISCHEK DENISE MChief Strategy OfficerJul 30 '26Option Exercise0.0026,1200152,629Jul 31
SIMON IRWIN DPresident and CEOJul 30 '26Option Exercise0.00117,6470801,666Jul 31
Merton Carl AChief Financial OfficerJul 30 '26Option Exercise0.0016,6560138,914Jul 31
Gendel MitchellGlobal General CounselJul 30 '26Option Exercise0.0024,3790135,304Jul 31
SIMON IRWIN DPresident and CEOJul 29 '26Option Exercise0.00428,4480911,097Jul 31
Gendel MitchellGlobal General CounselJul 29 '26Option Exercise0.0087,4400157,269Jul 31
FALTISCHEK DENISE MChief Strategy OfficerJul 29 '26Option Exercise0.0093,6850176,163Jul 31
Merton Carl AChief Financial OfficerJul 29 '26Option Exercise0.0060,4170152,467Jul 31
Hopkinson David G.DirectorJul 29 '26Option Exercise0.0043,104043,104Jul 30
Persofsky RenahDirectorJul 29 '26Option Exercise0.0043,1040176,909Jul 30
Looney Thomas P.DirectorJul 29 '26Option Exercise0.0043,1040397,520Jul 30
Herhalt Johann MichaelDirectorJul 29 '26Option Exercise0.0043,1040217,113Jul 30
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.